Etiology and outcome of acute recurrent pancreatitis and chronic pancreatitis.
acute recurrent pancreatitis
children
chronic pancreatitis
etiology
outcome
pancreatitis
Journal
Pediatrics international : official journal of the Japan Pediatric Society
ISSN: 1442-200X
Titre abrégé: Pediatr Int
Pays: Australia
ID NLM: 100886002
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
revised:
14
01
2022
received:
16
08
2021
accepted:
21
01
2022
pubmed:
7
5
2022
medline:
11
5
2022
entrez:
6
5
2022
Statut:
ppublish
Résumé
Owing to the lack of data, we aimed to determine the etiology and outcome of acute recurrent pancreatitis (ARP) and chronic pancreatitis (CP) in children in Southeast Asia. This retrospective study was conducted at a university hospital in Bangkok, Thailand. We included patients aged <18 years who were diagnosed with pancreatitis from 2000 to 2021. Among 155 patients with pancreatitis, 21 (13.5%) were diagnosed with either ARP (n = 7) or CP (n = 14). Clinical manifestations of CP included chronic abdominal pain (n = 10, 71.4%), steatorrhea (n = 8, 57.1%), and diabetes mellitus (n = 1, 7.1%). Positive radiological findings compatible with CP were detected from an abdominal ultrasound, computed tomography, magnetic resonance cholangiopancreatography in 70%, 90.9%, and 92.9% of patients, respectively. Genetic, metabolic, and pancreaticobiliary causes were the major causes of ARP/CP (23.8% each) and the etiologies were unidentified in one-fifth of the patients. Patients with metabolic diseases who had AP were at-risk of developing ARP (hazards ratio [HR], 4.7, 95% confidence interval [CI]: 1.5-13.9). Children with ARP or CP were younger than those with AP (P = 0.04). Approximately two-thirds of patients with CP had growth faltering and they had more episodes of hospitalization due to acute attacks when compared to patients with ARP ( 4 [interquartile range [IQR], 3-6] vs. 3 [IQR, 2-3]; P = 0.02). Genetic, metabolic, and pancreaticobiliary diseases were the common etiologies of ARP and CP among children living in a developing country in Southeast Asia. The burden of CP included malnutrition and frequent hospitalization. The findings emphasize the importance of an early etiological diagnosis and monitoring for pancreatic insufficiency in ARP/CP.
Sections du résumé
BACKGROUND
BACKGROUND
Owing to the lack of data, we aimed to determine the etiology and outcome of acute recurrent pancreatitis (ARP) and chronic pancreatitis (CP) in children in Southeast Asia.
METHODS
METHODS
This retrospective study was conducted at a university hospital in Bangkok, Thailand. We included patients aged <18 years who were diagnosed with pancreatitis from 2000 to 2021.
RESULTS
RESULTS
Among 155 patients with pancreatitis, 21 (13.5%) were diagnosed with either ARP (n = 7) or CP (n = 14). Clinical manifestations of CP included chronic abdominal pain (n = 10, 71.4%), steatorrhea (n = 8, 57.1%), and diabetes mellitus (n = 1, 7.1%). Positive radiological findings compatible with CP were detected from an abdominal ultrasound, computed tomography, magnetic resonance cholangiopancreatography in 70%, 90.9%, and 92.9% of patients, respectively. Genetic, metabolic, and pancreaticobiliary causes were the major causes of ARP/CP (23.8% each) and the etiologies were unidentified in one-fifth of the patients. Patients with metabolic diseases who had AP were at-risk of developing ARP (hazards ratio [HR], 4.7, 95% confidence interval [CI]: 1.5-13.9). Children with ARP or CP were younger than those with AP (P = 0.04). Approximately two-thirds of patients with CP had growth faltering and they had more episodes of hospitalization due to acute attacks when compared to patients with ARP ( 4 [interquartile range [IQR], 3-6] vs. 3 [IQR, 2-3]; P = 0.02).
CONCLUSION
CONCLUSIONS
Genetic, metabolic, and pancreaticobiliary diseases were the common etiologies of ARP and CP among children living in a developing country in Southeast Asia. The burden of CP included malnutrition and frequent hospitalization. The findings emphasize the importance of an early etiological diagnosis and monitoring for pancreatic insufficiency in ARP/CP.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e15145Informations de copyright
© 2022 Japan Pediatric Society.
Références
Lee PJ, Papachristou GI. New insights into acute pancreatitis. Nat. Rev. Gastroenterol. Hepatol. 2019; 16: 479-96.
Uc A, Husain SZ. Pancreatitis in children. Gastroenterology 2019; 156: 1969-78.
Coffey MJ, Ooi CY. Paediatric pancreatic diseases. J. Paediatr. Child Health 2020; 56: 1694-701.
Morinville VD, Husain SZ, Bai H et al. Definitions of pediatric pancreatitis and survey of current clinical practices: report from INSPPIRE (international study group of pediatric pancreatitis: in search for a cure). J. Pediatr. Gastroenterol. Nutr. 2012; 55: 261.
Kleeff J, Whitcomb DC, Shimosegawa T et al. Chronic pancreatitis. Nat. Rev. Dis. Primers 2017; 3: 17060.
Cheng Y-J, Yang H-Y, Tsai C-F et al. Epidemiology of pediatric acute pancreatitis in Taiwan: a nationwide population-based study. J. Pediatr. Gastroenterol. Nutr. 2019; 68: e7-12.
Husain SZ, Srinath AI. What's unique about acute pancreatitis in children: risk factors, diagnosis and management. Nat. Rev. Gastroenterol. Hepatol. 2017; 14: 366-72.
Gariepy CE, Heyman MB, Lowe ME et al. Causal evaluation of acute recurrent and chronic pancreatitis in children: consensus from the INSPPIRE group. J. Pediatr. Gastroenterol. Nutr. 2017; 64: 95-103.
Abu-El-Haija M, Nathan JD. Pediatric chronic pancreatitis: updates in the 21st century. Pancreatology 2018; 18: 354-9.
Schwarzenberg SJ, Bellin M, Husain SZ et al. Pediatric chronic pancreatitis is associated with genetic risk factors and substantial disease burden. J. Pediatr. 2015; 166: 890-96.e1.
Sánchez-Ramírez CA, Larrosa-Haro A, Flores-Martínez S, Sánchez-Corona J, Villa-Gómez A, Macías-Rosales R. Acute and recurrent pancreatitis in children: etiological factors. Acta Paediatr. 2007; 96: 534-7.
Lee YJ, Kim KM, Choi JH, Lee BH, Kim G-H, Yoo H-W. High incidence of PRSS1 and SPINK1 mutations in Korean children with acute recurrent and chronic pancreatitis. J. Pediatr. Gastroenterol. Nutr. 2011; 52: 478-81.
Minen F, De Cunto A, Martelossi S, Ventura A. Acute and recurrent pancreatitis in children: exploring etiological factors. Scand. J. Gastroenterol. 2012; 47: 1501-4.
Giefer MJ, Lowe ME, Werlin SL et al. Early-onset acute recurrent and chronic pancreatitis is associated with PRSS1 or CTRC gene mutations. J. Pediatr. 2017; 186: 95-100.
Gonzalez-Viana E, Dworzynski K, Murphy MS, Peek R. Faltering growth in children: summary of NICE guidance. BMJ 2017; 358: j4219.
Abu-El-Haija M, Valencia CA, Hornung L et al. Genetic variants in acute, acute recurrent and chronic pancreatitis affect the progression of disease in children. Pancreatology 2019; 19: 535-40.
Saito N, Suzuki M, Sakurai Y et al. Genetic analysis of Japanese children with acute recurrent and chronic pancreatitis. J. Pediatr. Gastroenterol. Nutr. 2016; 63: 431-6.
Xiao Y, Yuan W, Yu B et al. Targeted gene next-generation sequencing in Chinese children with chronic pancreatitis and acute recurrent pancreatitis. J. Pediatr. 2017; 191: 158-63.e3.
Lucidi V, Alghisi F, Dall'Oglio L et al. The etiology of acute recurrent pancreatitis in children: a challenge for pediatricians. Pancreas 2011; 40: 517-21.
Bosch B, Bilton D, Sosnay P et al. Ethnicity impacts the cystic fibrosis diagnosis: a note of caution. J. Cyst. Fibros. 2017; 16: 488-91.
Teeratakulpisarn J, Kosuwon P, Srinakarin J, Panthongviriyakul C, Sutra S. Cystic fibrosis in three northeast Thai infants is CF really a rare disease in the Thai population. J. Med. Assoc. Thai 2006; 89: 1756-61.
Marfil-Garza BA, Hefler J, Dajani K, Kin T, James Shapiro AM. Total pancreatectomy with islet cell autotransplantation in a 2-year-old child with hereditary pancreatitis due to a PRSS1 mutation. Am J Transplant. 2021; 21: 3790-3.
Schwarzenberg SJ, Uc A, Zimmerman B et al. Chronic pancreatitis: pediatric and adult cohorts show similarities in disease progress despite different risk factors. J. Pediatr. Gastroenterol. Nutr. 2019; 68: 566-73.
Lin TK, Abu-El-Haija M, Nathan JD et al. Pancreas divisum in pediatric acute recurrent and chronic pancreatitis: report from INSPPIRE. J. Clin. Gastroenterol. 2019; 53: e232-38.
Liu QY, Gugig R, Troendle DM et al. The roles of endoscopic ultrasound and endoscopic retrograde cholangiopancreatography in the evaluation and treatment of chronic pancreatitis in children: a position paper from the North American society for pediatric gastroenterology, hepatology, and nutrition pancreas committee. J. Pediatr. Gastroenterol. Nutr. 2020; 70: 681-93.
Kohoutova D, Tringali A, Papparella G et al. Endoscopic treatment of chronic pancreatitis in pediatric population: long-term efficacy and safety. United Eur. Gastroenterol. J. 2019; 7: 270-7.
Troendle DM, Fishman DS, Barth BA et al. Therapeutic endoscopic retrograde cholangiopancreatography in pediatric patients with acute recurrent and chronic pancreatitis: data from the INSPPIRE (INternational study group of pediatric pancreatitis: in search for a cuRE) study. Pancreas 2017; 46: 764-9.
Wen J, Li T, Liu L, Bie L-K, Gong B. Long-term outcomes of therapeutic ERCP in pediatric patients with pancreas divisum presenting with acute recurrent or chronic pancreatitis. Pancreatology 2019; 19: 834-41.
Husain SZ, Morinville V, Pohl J et al. Toxic-metabolic risk factors in pediatric pancreatitis: recommendations for diagnosis, management, and future research. J. Pediatr. Gastroenterol. Nutr. 2016; 62: 609-17.
Oracz G, Kolodziejczyk E, Wejnarska K, Kierkus J. Toxic-metabolic risk factors in pediatric chronic pancreatitis-single center experience. J. Pediatr. Gastroenterol. Nutr. 2016; 62: e66.
Ippisch HM, Alfaro-Cruz L, Fei L, Zou Y, Thompson T, Abu-El-Haija M. Hypertriglyceridemia induced pancreatitis: inpatient management at a single pediatric institution. Pancreas 2020; 49: 429-34.
Treepongkaruna S, Thongpak N, Pakakasama S, Pienvichit P, Sirachainan N, Hongeng S. Acute pancreatitis in children with acute lymphoblastic leukemia after chemotherapy. J. Pediatr. Hematol. Oncol. 2009; 31: 812-5.
Kearney SL, Dahlberg SE, Levy DE, Voss SD, Sallan SE, Silverman LB. Clinical course and outcome in children with acute lymphoblastic leukemia and asparaginase-associated pancreatitis. Pediatr. Blood. Cancer 2009; 53: 162-7.
Stock W, Douer D, DeAngelo DJ et al. Prevention and management of asparaginase/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panel. Leuk. Lymphoma 2011; 52: 2237-53.
Thai Pediatric Oncology Group. National protocol for the treatment of childhood cancers 2016. M Print Cooperation, Bangkok, 2016.
Wolthers BO, Frandsen TL, Patel CJ et al. Trypsin-encoding PRSS1-PRSS2 variations influence the risk of asparaginase-associated pancreatitis in children with acute lymphoblastic leukemia: a Ponte di Legno toxicity working group report. Haematologica 2019; 104 (3):556-63.
Poddar U, Yachha SK, Borkar V, Srivastava A, Kumar S. A report of 320 cases of childhood pancreatitis: increasing incidence, etiologic categorization, dynamics, severity assessment, and outcome. Pancreas 2017; 46: 110-5.
Darge K, Anupindi S. Pancreatitis and the role of US. MRCP and ERCP. Pediatr. Radiol. 2009; 39: 153-7.
de la Iglesia-García D, Huang W, Szatmary P et al. Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis. Gut 2017; 66: 1354.
Srivastava A, Saini N, Mathias A, Arya A, Jain S, Yachha SK. Prevalence and predictive factors of undernutrition and low bone mineral density in children with chronic pancreatitis. Pancreatology 2021; 21: 74-80.
Freeman AJ, Maqbool A, Bellin MD et al. Medical management of chronic pancreatitis in children: a position paper by the North American society for pediatric gastroenterology, hepatology, and nutrition pancreas committee. J. Pediatr. Gastroenterol. Nutr. 2021; 72: 324-40.
Bellin MD, Lowe M, Zimmerman MB et al. Diabetes mellitus in children with acute recurrent and chronic pancreatitis: data from the INternational study group of pediatric pancreatitis. In search for a CuRE cohort. J. Pediatr. Gastroenterol. Nutr. 2019; 69: 599-606.
Kumar S, Ooi CY, Werlin S et al. Risk factors associated with pediatric acute recurrent and chronic pancreatitis: lessons from INSPPIRE. JAMA Pediatr. 2016; 170: 562-9.
Scheers I, Palermo JJ, Freedman S et al. Autoimmune pancreatitis in children: characteristic features, diagnosis, and management. Am. J. Gastroenterol. 2017; 112: 1604-11.